因 COVID-19 而延迟行经导管主动脉瓣置换术患者的特征和结局。
Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19.
机构信息
Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, New York.
出版信息
JAMA Netw Open. 2020 Sep 1;3(9):e2019801. doi: 10.1001/jamanetworkopen.2020.19801.
Abstract
This cohort study examines the characteristics and outcomes of patients for whom transcatheter aortic valve replacement (TAVR) was deferred because of the coronavirus disease 2019 (COVID-19) pandemic.
摘要
本队列研究探讨了因 2019 年冠状病毒病（COVID-19）大流行而推迟行经导管主动脉瓣置换术（TAVR）的患者的特征和结局。
相似文献
1
Characteristics and Outcomes of Patients Deferred for Transcatheter Aortic Valve Replacement Because of COVID-19.因 COVID-19 而延迟行经导管主动脉瓣置换术患者的特征和结局。
JAMA Netw Open. 2020 Sep 1;3(9):e2019801. doi: 10.1001/jamanetworkopen.2020.19801.
2
Mortality, Stroke, and Hospitalization Associated With Deferred vs Expedited Aortic Valve Replacement in Patients Referred for Symptomatic Severe Aortic Stenosis During the COVID-19 Pandemic.在 COVID-19 大流行期间，因症状性重度主动脉瓣狭窄而接受主动脉瓣置换术的患者中，与延迟 vs 紧急主动脉瓣置换相关的死亡率、卒中和住院情况。
JAMA Netw Open. 2020 Sep 1;3(9):e2020402. doi: 10.1001/jamanetworkopen.2020.20402.
3
Unexpected peak of mortality: The COVID-19 burden on Bergamo transcatheter aortic valve implantation register.意外的死亡率高峰：COVID-19对贝加莫经导管主动脉瓣植入登记处的影响。
Anatol J Cardiol. 2020 Sep;24(3):209-210. doi: 10.14744/AnatolJCardiol.2020.01955.
4
Heartbeat: Heart disease and COVID-19.心跳：心脏病与2019冠状病毒病
Heart. 2020 Aug;106(15):1115-1116. doi: 10.1136/heartjnl-2020-317674.
5
Managing Aortic Stenosis in the Age of COVID-19: Preparing for the Second Wave.在新冠疫情时代管理主动脉瓣狭窄：为第二波疫情做准备
JAMA Netw Open. 2020 Sep 1;3(9):e2020368. doi: 10.1001/jamanetworkopen.2020.20368.
6
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic.COVID-19大流行期间严重主动脉瓣狭窄的经导管治疗
Heart. 2020 Aug;106(15):1183-1190. doi: 10.1136/heartjnl-2020-317221. Epub 2020 Jun 10.
7
Management of elective aortic valve replacement over the long term in the era of COVID-19.COVID-19时代择期主动脉瓣置换术的长期管理
Eur J Cardiothorac Surg. 2020 Jun 1;57(6):1029-1031. doi: 10.1093/ejcts/ezaa152.
8
"Minimalist" transcatheter aortic valve implantation during the COVID-19 pandemic: previously optional but now a necessity.新冠疫情期间的“极简式”经导管主动脉瓣植入术：以往是可选项，如今成了必选项。
EuroIntervention. 2020 Aug 7;16(6):e451-e452. doi: 10.4244/EIJV16I6A82.
9
Severe aortic stenosis patient risk during the COVID-19 pandemic.新冠疫情期间重度主动脉瓣狭窄患者的风险
Open Heart. 2020 Sep;7(2). doi: 10.1136/openhrt-2020-001355.
10
Transcatheter Aortic Valve Replacement in the Coronavirus Disease 2019 (COVID-19) Era.2019年冠状病毒病（COVID-19）时代的经导管主动脉瓣置换术
J Am Heart Assoc. 2020 Jun 2;9(11):e017121. doi: 10.1161/JAHA.120.017121. Epub 2020 May 26.
引用本文的文献
1
Deferral of scheduled transcatheter heart valve interventions strongly increases the risk of congestive heart failure.推迟预定的经导管心脏瓣膜介入治疗会显著增加充血性心力衰竭的风险。
Sci Rep. 2025 Sep 1;15(1):32151. doi: 10.1038/s41598-025-16742-7.
2
Differential Characteristics and Outcomes of Urgent/Emergent Versus Elective Aortic Valve Replacement.急诊/紧急与择期主动脉瓣置换术的差异特征及结果
J Am Heart Assoc. 2025 Jun 3;14(11):e041148. doi: 10.1161/JAHA.125.041148. Epub 2025 May 29.
3
The Cost of Waiting for a Transcatheter Aortic Valve Replacement in Medicare Beneficiaries With Severe Aortic Stenosis.医疗保险重度主动脉瓣狭窄受益人等待经导管主动脉瓣置换术的成本
Struct Heart. 2024 Jun 12;8(6):100321. doi: 10.1016/j.shj.2024.100321. eCollection 2024 Nov.
4
Telemedical management in patients waiting for transcatheter aortic valve implantation: the ResKriVer-TAVI study design.等待经导管主动脉瓣植入患者的远程医疗管理：ResKriVer-TAVI研究设计
Front Cardiovasc Med. 2024 Jan 22;10:1352592. doi: 10.3389/fcvm.2023.1352592. eCollection 2023.
5
Elective operations delay and emergency department visits and inpatient admissions during COVID-19.新冠疫情期间的择期手术延迟以及急诊科就诊和住院情况。
Surg Pract Sci. 2022 Sep;10:100111. doi: 10.1016/j.sipas.2022.100111. Epub 2022 Jul 11.
6
National Trends of Structural Heart Disease Interventions from 2016 to 2020 in the United States and the Associated Impact of COVID-19 Pandemic.美国 2016 年至 2020 年结构性心脏病介入治疗的国家趋势及 COVID-19 大流行的相关影响。
Curr Probl Cardiol. 2023 Mar;48(3):101526. doi: 10.1016/j.cpcardiol.2022.101526. Epub 2022 Nov 28.
7
The Ongoing National Medical Staffing Crisis: Impacts on Care Delivery for Interventional Cardiologists.持续的全国医疗人员短缺危机：对介入心脏病专家护理服务的影响。
J Soc Cardiovasc Angiogr Interv. 2022 May-Jun;1(3):100307. doi: 10.1016/j.jscai.2022.100307. Epub 2022 Apr 15.
8
Aortic stenosis post-COVID-19: a mathematical model on waiting lists and mortality.COVID-19 后主动脉瓣狭窄：等待名单和死亡率的数学模型。
BMJ Open. 2022 Jun 16;12(6):e059309. doi: 10.1136/bmjopen-2021-059309.
9
Best Practice Recommendations for Optimizing Care in Structural Heart Programs: Planning Efficient and Resource Leveraging Systems (PEARLS).优化结构性心脏病项目护理的最佳实践建议：规划高效且资源利用合理的系统（PEARLS）。
Struct Heart. 2021 Mar-Apr;5(2):168-179. doi: 10.1080/24748706.2021.1877858. Epub 2022 Mar 21.
10
Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020.2020 年经导管主动脉瓣置换术与单纯外科主动脉瓣置换术的比较。
Clin Res Cardiol. 2022 Aug;111(8):924-933. doi: 10.1007/s00392-022-02006-1. Epub 2022 Apr 1.
本文引用的文献
1
Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the Week.在 COVID-19 大流行期间重构结构性心脏病实践：JACC 每周综述专题。
J Am Coll Cardiol. 2020 Jun 16;75(23):2974-2983. doi: 10.1016/j.jacc.2020.04.009. Epub 2020 Apr 9.
2
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic: An ACC/SCAI Position Statement.COVID-19 大流行期间结构性心脏病介入治疗转诊患者的分诊考虑：ACC/SCAI 立场声明。
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1484-1488. doi: 10.1016/j.jcin.2020.04.001. Epub 2020 Apr 6.
Zotero 插件